332402005: Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet (clinical drug)

SNOMED CT Concept\Pharmaceutical / biologic product\...

\UK product\Virtual medicinal product\Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet
\UK product\Virtual therapeutic moiety\Co-cyprindiol\Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet

\Medicinal product\Medicinal product categorized by disposition\Product containing hormone receptor antagonist\Product containing androgen receptor antagonist\Co-cyprindiol\Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet
\Medicinal product\Medicinal product categorized by disposition\Product containing hormone receptor antagonist\Product containing androgen receptor antagonist\Product containing cyproterone\Product containing cyproterone and ethinylestradiol\Product containing only cyproterone and ethinylestradiol (medicinal product)\Product containing only cyproterone and ethinylestradiol in oral dose form (medicinal product form)\Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet
\Medicinal product\Medicinal product categorized by disposition\Product containing hormone receptor antagonist\Product containing androgen receptor antagonist\Product containing cyproterone\Product containing cyproterone and ethinylestradiol\Product containing cyproterone and ethinylestradiol in oral dose form (medicinal product form)\Product containing only cyproterone and ethinylestradiol in oral dose form (medicinal product form)\Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet
\Medicinal product\Medicinal product categorized by disposition\Product containing hormone receptor antagonist\Product containing androgen receptor antagonist\Product containing cyproterone\Product containing cyproterone in oral dose form (medicinal product form)\Product containing cyproterone and ethinylestradiol in oral dose form (medicinal product form)\Product containing only cyproterone and ethinylestradiol in oral dose form (medicinal product form)\Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet
\Medicinal product\Medicinal product categorized by disposition\Product containing hormone\Product containing cyproterone\Product containing cyproterone and ethinylestradiol\Product containing only cyproterone and ethinylestradiol (medicinal product)\Product containing only cyproterone and ethinylestradiol in oral dose form (medicinal product form)\Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet
\Medicinal product\Medicinal product categorized by disposition\Product containing hormone\Product containing cyproterone\Product containing cyproterone and ethinylestradiol\Product containing cyproterone and ethinylestradiol in oral dose form (medicinal product form)\Product containing only cyproterone and ethinylestradiol in oral dose form (medicinal product form)\Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet
\Medicinal product\Medicinal product categorized by disposition\Product containing hormone\Product containing cyproterone\Product containing cyproterone in oral dose form (medicinal product form)\Product containing cyproterone and ethinylestradiol in oral dose form (medicinal product form)\Product containing only cyproterone and ethinylestradiol in oral dose form (medicinal product form)\Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet
\Medicinal product\Medicinal product categorized by disposition\Product containing hormone\Product containing estrogen receptor agonist (product)\Product containing ethinylestradiol\Product containing ethinylestradiol in oral dose form (medicinal product form)\Product containing cyproterone and ethinylestradiol in oral dose form (medicinal product form)\Product containing only cyproterone and ethinylestradiol in oral dose form (medicinal product form)\Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet
\Medicinal product\Medicinal product categorized by disposition\Product containing hormone\Product containing estrogen receptor agonist (product)\Product containing ethinylestradiol\Product containing cyproterone and ethinylestradiol\Product containing only cyproterone and ethinylestradiol (medicinal product)\Product containing only cyproterone and ethinylestradiol in oral dose form (medicinal product form)\Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet
\Medicinal product\Medicinal product categorized by disposition\Product containing hormone\Product containing estrogen receptor agonist (product)\Product containing ethinylestradiol\Product containing cyproterone and ethinylestradiol\Product containing cyproterone and ethinylestradiol in oral dose form (medicinal product form)\Product containing only cyproterone and ethinylestradiol in oral dose form (medicinal product form)\Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet
\Medicinal product\Medicinal product categorized by structure\Product containing steroid\Product containing pregnane\Product containing cyproterone\Product containing cyproterone and ethinylestradiol\Product containing only cyproterone and ethinylestradiol (medicinal product)\Product containing only cyproterone and ethinylestradiol in oral dose form (medicinal product form)\Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet
\Medicinal product\Medicinal product categorized by structure\Product containing steroid\Product containing pregnane\Product containing cyproterone\Product containing cyproterone and ethinylestradiol\Product containing cyproterone and ethinylestradiol in oral dose form (medicinal product form)\Product containing only cyproterone and ethinylestradiol in oral dose form (medicinal product form)\Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet
\Medicinal product\Medicinal product categorized by structure\Product containing steroid\Product containing pregnane\Product containing cyproterone\Product containing cyproterone in oral dose form (medicinal product form)\Product containing cyproterone and ethinylestradiol in oral dose form (medicinal product form)\Product containing only cyproterone and ethinylestradiol in oral dose form (medicinal product form)\Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet
\Medicinal product\Medicinal product categorized by structure\Product containing steroid\Product containing ethinylestradiol\Product containing ethinylestradiol in oral dose form (medicinal product form)\Product containing cyproterone and ethinylestradiol in oral dose form (medicinal product form)\Product containing only cyproterone and ethinylestradiol in oral dose form (medicinal product form)\Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet
\Medicinal product\Medicinal product categorized by structure\Product containing steroid\Product containing ethinylestradiol\Product containing cyproterone and ethinylestradiol\Product containing only cyproterone and ethinylestradiol (medicinal product)\Product containing only cyproterone and ethinylestradiol in oral dose form (medicinal product form)\Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet
\Medicinal product\Medicinal product categorized by structure\Product containing steroid\Product containing ethinylestradiol\Product containing cyproterone and ethinylestradiol\Product containing cyproterone and ethinylestradiol in oral dose form (medicinal product form)\Product containing only cyproterone and ethinylestradiol in oral dose form (medicinal product form)\Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as antiacne agent (product)\Product containing cyproterone and ethinylestradiol in oral dose form (medicinal product form)\Product containing only cyproterone and ethinylestradiol in oral dose form (medicinal product form)\Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet
\Medicinal product\Medicinal product categorized by therapeutic role\Medicinal product acting as contraceptive (product)\Product containing cyproterone and ethinylestradiol in oral dose form (medicinal product form)\Product containing only cyproterone and ethinylestradiol in oral dose form (medicinal product form)\Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet
\Medicinal product\Product manufactured as oral dose form\Product containing ethinylestradiol in oral dose form (medicinal product form)\Product containing cyproterone and ethinylestradiol in oral dose form (medicinal product form)\Product containing only cyproterone and ethinylestradiol in oral dose form (medicinal product form)\Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet
\Medicinal product\Product manufactured as oral dose form\Product containing cyproterone in oral dose form (medicinal product form)\Product containing cyproterone and ethinylestradiol in oral dose form (medicinal product form)\Product containing only cyproterone and ethinylestradiol in oral dose form (medicinal product form)\Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module

3699591011 Cyproterone acetate 2 mg and ethinyl estradiol 35 microgram oral tablet en Synonym Active Entire term case insensitive SNOMED CT core module

3699593014 Cyproterone acetate 2 mg and ethinylestradiol 35 microgram oral tablet en Synonym Active Entire term case insensitive SNOMED CT core module

3699594015 Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive SNOMED CT core module

46773601000001114 Co-cyprindiol 2000microgram/35microgram tablets en Synonym Active Entire term case sensitive SNOMED CT United Kingdom Edition module

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Is a	Product containing cyproterone acetate and ethinyl estradiol	false	Inferred relationship	Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Has active ingredient	Cyproterone	false	Inferred relationship	Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Has active ingredient	Hormone	false	Inferred relationship	Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Has active ingredient	Hormones and their metabolites and precursors	false	Inferred relationship	Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Has manufactured dose form	Tablet	false	Inferred relationship	Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Has active ingredient	Ethinylestradiol	false	Inferred relationship	Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Has active ingredient	Cyproterone acetate	false	Inferred relationship	Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Has active ingredient	Estradiol	false	Inferred relationship	Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Has manufactured dose form	Conventional release oral tablet	false	Inferred relationship	Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Is a	Product containing estradiol in oral dose form (medicinal product form)	false	Inferred relationship	Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Has active ingredient	Ethinylestradiol	false	Inferred relationship	Existential restriction modifier	1
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Has basis of strength substance	Ethinylestradiol	true	Inferred relationship	Existential restriction modifier	1
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Has presentation strength denominator value	1	false	Inferred relationship	Existential restriction modifier	1
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Has presentation strength denominator unit	Tablet	true	Inferred relationship	Existential restriction modifier	1
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Has active ingredient	Cyproterone acetate	false	Inferred relationship	Existential restriction modifier	2
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Has basis of strength substance	Cyproterone acetate	true	Inferred relationship	Existential restriction modifier	2
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Has presentation strength numerator unit	microgram	false	Inferred relationship	Existential restriction modifier	2
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Has presentation strength denominator value	1	false	Inferred relationship	Existential restriction modifier	2
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Has presentation strength denominator unit	Tablet	true	Inferred relationship	Existential restriction modifier	2
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Has basis of strength substance	Cyproterone acetate	false	Inferred relationship	Existential restriction modifier	1
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Has basis of strength substance	Ethinylestradiol	false	Inferred relationship	Existential restriction modifier	2
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Has presentation strength numerator value	35	false	Inferred relationship	Existential restriction modifier	2
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Has presentation strength numerator value	2	false	Inferred relationship	Existential restriction modifier	1
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Has presentation strength numerator unit	milligram	false	Inferred relationship	Existential restriction modifier	1
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Has presentation strength numerator unit	milligram	true	Inferred relationship	Existential restriction modifier	2
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Has presentation strength numerator value	0.035	false	Inferred relationship	Existential restriction modifier	1
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Has presentation strength numerator value	2	false	Inferred relationship	Existential restriction modifier	2
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Has unit of presentation	Tablet	false	Inferred relationship	Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Has precise active ingredient	Cyproterone acetate	false	Inferred relationship	Existential restriction modifier	1
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Has precise active ingredient	Ethinylestradiol	false	Inferred relationship	Existential restriction modifier	2
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Is a	Product containing cyproterone and ethinylestradiol in oral dose form (medicinal product form)	false	Inferred relationship	Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Count of base of active ingredient	2	false	Inferred relationship	Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Plays role	Contraceptive therapeutic role	true	Inferred relationship	Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Plays role	Antiacne therapeutic role	true	Inferred relationship	Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Is a	Product containing only cyproterone and ethinylestradiol in oral dose form (medicinal product form)	true	Inferred relationship	Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Has precise active ingredient	Ethinylestradiol	true	Inferred relationship	Existential restriction modifier	1
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Has presentation strength numerator unit	microgram	true	Inferred relationship	Existential restriction modifier	1
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Has precise active ingredient	Cyproterone acetate	true	Inferred relationship	Existential restriction modifier	2
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Has manufactured dose form	Oral dose form	true	Inferred relationship	Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Count of base of active ingredient	2	false	Inferred relationship	Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Has manufactured dose form	Conventional release oral tablet	false	Inferred relationship	Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Has unit of presentation	Tablet	false	Inferred relationship	Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Has active ingredient	Ethinylestradiol	false	Inferred relationship	Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Has NHS dm+d (dictionary of medicines and devices) dose form indicator	Discrete dose form indicator	true	Inferred relationship	Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Has NHS dm+d (dictionary of medicines and devices) controlled drug category	Controlled drug category No Controlled Drug Status	true	Inferred relationship	Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route	tablet.oral ontology form and route	true	Inferred relationship	Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration	Oral route	true	Inferred relationship	Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Count of base of active ingredient	2	false	Inferred relationship	Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Has unit of presentation	Tablet	false	Inferred relationship	Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Has manufactured dose form	Conventional release oral tablet	false	Inferred relationship	Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Has active ingredient	Cyproterone	false	Inferred relationship	Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Has manufactured dose form	Conventional release oral tablet	false	Inferred relationship	Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Count of base of active ingredient	2	false	Inferred relationship	Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Has unit of presentation	Tablet	false	Inferred relationship	Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Has manufactured dose form	Tablet	false	Inferred relationship	Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Count of base of active ingredient	2	false	Inferred relationship	Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	VMP prescribing status (attribute)	VMP valid as a prescribable product	true	Inferred relationship	Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	VMP non-availability indicator	Available	true	Inferred relationship	Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Has manufactured dose form	Tablet	false	Inferred relationship	Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Has specific active ingredient	Cyproterone acetate	true	Inferred relationship	Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Has specific active ingredient	Ethinylestradiol	true	Inferred relationship	Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Has dispensed dose form	Tablet	true	Inferred relationship	Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Is a	Virtual medicinal product	true	Inferred relationship	Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Is a	Co-cyprindiol	true	Inferred relationship	Existential restriction modifier
Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Has manufactured dose form	Tablet	false	Inferred relationship	Existential restriction modifier

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Cyproterone acetate+ethinyloestradiol 2mg/35micrograms tablet - product	Is a	False	Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Inferred relationship	Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets (CST Pharma Ltd)	Is a	True	Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Inferred relationship	Existential restriction modifier
Dianette tablets (Schering Health Care Ltd)	Is a	True	Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Inferred relationship	Existential restriction modifier
Dianette tablets (PI) (Dowelhurst Ltd)	Is a	True	Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Inferred relationship	Existential restriction modifier
Dianette tablets (PI) (Waymade Ltd)	Is a	True	Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Inferred relationship	Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets (Kent Pharma (UK) Ltd)	Is a	True	Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Inferred relationship	Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets (Unichem Plc)	Is a	True	Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Inferred relationship	Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets (A A H Pharmaceuticals Ltd)	Is a	True	Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Inferred relationship	Existential restriction modifier
Acnocin 2000microgram/35microgram tablets (Sandoz Ltd)	Is a	True	Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Inferred relationship	Existential restriction modifier
Diva 2000/35 tablets (Zeroderma Ltd)	Is a	True	Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Inferred relationship	Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets (Zentiva Pharma UK Ltd)	Is a	True	Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Inferred relationship	Existential restriction modifier
Dianette tablets (CST Pharma Ltd)	Is a	True	Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Inferred relationship	Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets (Somex Pharma)	Is a	True	Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Inferred relationship	Existential restriction modifier
Cicafem 2000/35 tablets (koGEN Limited)	Is a	True	Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Inferred relationship	Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets 63 tablet	Is pack of	False	Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Inferred relationship	Existential restriction modifier
Clairette 2000/35 tablets (Kent Pharma (UK) Ltd)	Is a	True	Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Inferred relationship	Existential restriction modifier
Dianette tablets (Viatris UK Healthcare Ltd)	Is a	True	Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Inferred relationship	Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets (Morningside Healthcare Ltd)	Is a	True	Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Inferred relationship	Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets (Medihealth (Northern) Ltd)	Is a	True	Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Inferred relationship	Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets (PLIVA Pharma Ltd)	Is a	True	Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Inferred relationship	Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets 21 tablet	Is pack of	False	Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Inferred relationship	Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets (Almus Pharmaceuticals Ltd)	Is a	True	Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Inferred relationship	Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets (Ranbaxy (UK) Ltd)	Is a	True	Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Inferred relationship	Existential restriction modifier
Dianette tablets (Sigma Pharmaceuticals Plc)	Is a	True	Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Inferred relationship	Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets (Sigma Pharmaceuticals Plc)	Is a	True	Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Inferred relationship	Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets 63 tablet	Has VMP	True	Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Inferred relationship	Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets 21 tablet	Has VMP	True	Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Inferred relationship	Existential restriction modifier
Dianette tablets (Lexon (UK) Ltd)	Is a	True	Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Inferred relationship	Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets (Phoenix Healthcare Distribution Ltd)	Is a	True	Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Inferred relationship	Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets (Fannin (UK) Ltd)	Is a	True	Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Inferred relationship	Existential restriction modifier
Dianette tablets (Mawdsley-Brooks & Company Ltd)	Is a	True	Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Inferred relationship	Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets (Waymade Healthcare Plc)	Is a	True	Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Inferred relationship	Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets (Doncaster Pharmaceuticals Ltd)	Is a	True	Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Inferred relationship	Existential restriction modifier
Teragezza 2000microgram/35microgram tablets (Morningside Healthcare Ltd)	Is a	True	Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Inferred relationship	Existential restriction modifier
Co-cyprindiol 2000microgram/35microgram tablets (Mawdsley-Brooks & Company Ltd)	Is a	True	Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet	Inferred relationship	Existential restriction modifier

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
3699591011	Cyproterone acetate 2 mg and ethinyl estradiol 35 microgram oral tablet	en	Synonym	Active	Entire term case insensitive	SNOMED CT core module
3699593014	Cyproterone acetate 2 mg and ethinylestradiol 35 microgram oral tablet	en	Synonym	Active	Entire term case insensitive	SNOMED CT core module
3699594015	Product containing precisely cyproterone acetate 2 milligram and ethinylestradiol 35 microgram/1 each conventional release oral tablet (clinical drug)	en	Fully specified name	Active	Entire term case insensitive	SNOMED CT core module
46773601000001114	Co-cyprindiol 2000microgram/35microgram tablets	en	Synonym	Active	Entire term case sensitive	SNOMED CT United Kingdom Edition module